Orthopediatrics CORP Form 4 insider transactions

Fred Hite, COO and CFO of Orthopediatrics Corp., reports acquisition of shares via vesting and disposition of shares to cover tax obligations.

Gregory A. Odle, President of Scoliosis at Orthopediatrics Corp., reports acquisition and disposal of company stock on March 15 and 18, 2025.

Joseph W. Hauser, an officer at Orthopediatrics Corp, reports acquisition and disposal of company stock, including shares to cover tax obligations.

OrthoPediatrics Corp. CEO David R. Bailey reported a gift of 1,500 common stock shares, with no monetary transaction involved, on December 27, 2024.

Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp., sold 10,000 shares of common stock on August 21, 2024.

Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp., reports acquisition of shares.

Joseph W. Hauser, an officer at Orthopediatrics Corp, acquired 37,936 shares of common stock on June 11, 2024.

Director Mark C. Throdahl reports acquiring 21,623 shares of Orthopediatrics Corp. common stock on June 11, 2024.

Gregory A. Odle, President of Scoliosis at Orthopediatrics Corp., reports acquiring 34,901 shares of common stock on June 11, 2024.

Fred Hite, COO and CFO of Orthopediatrics Corp., reports the acquisition of 57,018 shares of common stock on June 11, 2024.

Orthopediatrics Corp.'s CEO, David R. Bailey, acquired 90,395 shares of common stock on June 11, 2024.

Director Ruf Harold reported gifting 2,766 shares of Orthopediatrics Corp common stock to The Last Chance Legacy Trust.

Director Harold Ruf reports gifting of Orthopediatrics Corp. stock and holdings in a Roth IRA.

Director Jimmy Duane McDonald acquired 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director Ruf Harold reports acquiring 2,766 shares of Orthopediatrics Corp. common stock on May 28, 2024.

Director Marie C Infante reports acquiring 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director Samuel D. Riccitelli acquired 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director George Sinclair Mitchell Dyer acquired 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director Terry D. Schlotterback reported acquiring 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.

Director Bryan W. Hughes reported acquiring 2,766 shares of Orthopediatrics Corp. common stock on May 28, 2024.

Director David R. Pelizzon reports acquiring 2,766 shares of Orthopediatrics Corp stock at $0, increasing his direct holdings to 24,547 shares.

Orthopediatrics Corp.'s CEO, David R. Bailey, sold 3,213 shares of common stock on March 11, 2024, to satisfy tax withholding obligations related to vesting restricted shares.

Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp., sold 2,741 shares of common stock on March 11, 2024, to satisfy tax withholding obligations.

Gregory A. Odle, President of Scoliosis at Orthopediatrics Corp., sold 2,768 shares of common stock on March 11, 2024, to satisfy tax withholding obligations upon the vesting of restricted shares.

Mark C. Throdahl, a director at Orthopediatrics Corp., sold 2,433 shares of common stock on March 11, 2024, to satisfy tax withholding obligations.

Fred Hite, COO and CFO of Orthopediatrics Corp., sold 3,195 shares of common stock on March 11, 2024, to satisfy tax withholding obligations upon the vesting of restricted shares.